Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07179614 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Kentucky Women's Justice Community Overdose Innovation Network - Phase II

Study acronym: WJCOIN-II
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 2 to 3
    • Eligibility criteria expanded, about 7 words
  2. Study sites: 1 to 2v9
  3. Recruitment opened
    • Start date changed from estimate of May 18, 2026 to Jun 23, 2026
    • Study site revised
    v8
  4. Start date: Apr 15, 2026 to May 18, 2026v7
  5. Primary completion date: Oct 2030 to Oct 30, 2030v6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Feb 2026 to Apr 15, 2026v5
  2. Start date: Nov 1, 2025 to Feb 2026
    • Primary completion date: Oct 30, 2030 to Oct 2030
    v4
  3. Re-verified, no change to tracked fieldsv3
  4. Lead sponsor: University of Kentucky to Michele Staton
    • Study sites: 0 to 1
    • Collaborators expanded, about 6 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transition from jail to rural communities. WJCOIN-II has potential for significant impact regarding the effectiveness, implementation, and sustainability of innovative overdose prevention strategies during the high-risk time of community re-entry among vulnerable, CLS-involved women in rural communities. This research will impact the field by increasing the capacity of the criminal legal system to respond to the overdose crisis through increased access to prevention strategies to reduce overdose risk.
Trial Details
NCT Number NCT07179614
Lead Sponsor Michele Staton
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions
(from sponsor)		 Overdose Risk, Opioid Use Disorder, Stimulant Use Disorders
Related terms Drug Overdose, Opioid-Related Disorders
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov